Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay Sharma

Showing results (271-280 of 326) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell TransplantNicole Liberio, Mariam Allbee-Johnson, Kwang Woo Ahn, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy|October 12, 2021
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research AnalysisVijaya Raj Bhatt, Tao Wang, Karen Chen, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
Journal of Hematology & Oncology|June 27, 2024
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trialSwati Naik, Ying Li, Aimee C Talleur, et al.
The New England Journal of Medicine|December 7, 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaHaydar Frangoul, David Altshuler, M Domenica Cappellini, et al.
Blood Advances|December 12, 2025
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant RecipientsMiki Nishitani, Rudi-Ann Tamara Graham, Tao Wang, et al.
Transplantation and Cellular Therapy|October 16, 2023
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Blood Advances|April 1, 2026
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic AnemiaPhillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera, et al.
Leukemia|March 31, 2021
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTRMatthew J Wieduwilt, Wendy Stock, Anjali Advani, et al.
Pageof 33

Showing results (271-280 of 326) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell TransplantNicole Liberio, Mariam Allbee-Johnson, Kwang Woo Ahn, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy|October 12, 2021
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research AnalysisVijaya Raj Bhatt, Tao Wang, Karen Chen, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
Journal of Hematology & Oncology|June 27, 2024
Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trialSwati Naik, Ying Li, Aimee C Talleur, et al.
The New England Journal of Medicine|December 7, 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaHaydar Frangoul, David Altshuler, M Domenica Cappellini, et al.
Blood Advances|December 12, 2025
Impact of Age on Graft-vs-Host Disease and Overall Survival in Pediatric Hematopoietic Cell Transplant RecipientsMiki Nishitani, Rudi-Ann Tamara Graham, Tao Wang, et al.
Transplantation and Cellular Therapy|October 16, 2023
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.
Blood Advances|April 1, 2026
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic AnemiaPhillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera, et al.
Leukemia|March 31, 2021
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTRMatthew J Wieduwilt, Wendy Stock, Anjali Advani, et al.
Pageof 33